The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Nimotuzumab combined with cisplatin plus fluorouracil chemotherapy in patients with metastatic nasopharyngeal carcinoma after radical radiotherapy: A multicentre, open-label, phase II clinical trial.
 
Chong Zhao
No Relationships to Disclose
 
Jingjing Miao
No Relationships to Disclose
 
Guanzhu Shen
No Relationships to Disclose
 
Jin-Gao Li
No Relationships to Disclose
 
Ning Zhang
No Relationships to Disclose
 
Mei Shi
No Relationships to Disclose
 
Lin Wang
No Relationships to Disclose
 
Guoqing Hu
No Relationships to Disclose
 
Xiaozhong Chen
No Relationships to Disclose
 
Xuefeng Hu
No Relationships to Disclose
 
Shi Xiu Wu
No Relationships to Disclose
 
Jiaxin Chen
No Relationships to Disclose
 
Xunfan Shao
No Relationships to Disclose
 
Conghua Xie
No Relationships to Disclose